Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment

Clinical trial NCT04058197 · WITHDRAWN

Trial details

NCT number: NCT04058197
Sponsor: TauTona Group
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Cutaneous Ulcer Sickle Cell Disease

Start date: 2020-07-21
Primary completion: 2021-10-06
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.